Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery

Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery

Click the title to purchase the article.

Objectives: "The authors stopped using tranexamic acid (TXA) in April 2013. The present study aimed to examine the impact of a “no-TXA-use” policy by comparing the adverse effects of TXA and clinical outcomes before and after the policy change in patients undergoing cardiovascular surgery."1


1. Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery
Maeda T, Ishihara T, Miyata S, Yamashita K, Sasaki H et al.
J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1627-1634
Editorial

 

Recent Stories
Combined Monitoring—Brain Function Monitoring and Cerebral Oximetry

New Developments in Hemodynamic Monitoring

Noninvasive Continuous Hemoglobin Monitoring: Role in Cardiovascular Surgery

AmSECT Membership Eligibility

An Active Member shall be any perfusionist active in the practice of extracorporeal circulation technology. There are also opportunities to become a Transitional Active Member for those less than a year removed from graduation from an approved accredited training program. Other options include; an Associate Membership, International Membership, Perioperative Blood Management Clinician Membership, and Student Membership.

Click Here to Learn More

Looking for Employment Opportunities?

AmSECT members may post an available position for a perfusion specialty at your institution or firm.

Non-members may also post positions free of charge, to be reviewed by National Headquarters prior to posting.

Members - Click to Post a Position
Non-Members - Click to Post a Position

Contact AmSECT


AmSECT National Headquarters
330 N Wabash Ave, Suite 2000
Chicago, IL 60611

  Phone: (312) 321-5156
  Fax: (312) 673-6656
  Email: amsect@amsect.org

AmSECT © 2019 | View Privacy Policy | Site Map